These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31822268)

  • 1. Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.
    Lee KH; Han JW; Kim EY; Yun JS; Park YL; Park CH
    BMC Cancer; 2019 Dec; 19(1):1201. PubMed ID: 31822268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
    Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
    Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
    Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
    Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
    Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
    BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative breast MRI positively impacts surgical outcomes of needle biopsy-diagnosed pure DCIS: a patient-matched analysis from the MIPA study.
    Cozzi A; Di Leo G; Houssami N; Gilbert FJ; Helbich TH; Álvarez Benito M; Balleyguier C; Bazzocchi M; Bult P; Calabrese M; Camps Herrero J; Cartia F; Cassano E; Clauser P; de Lima Docema MF; Depretto C; Dominelli V; Forrai G; Girometti R; Harms SE; Hilborne S; Ienzi R; Lobbes MBI; Losio C; Mann RM; Montemezzi S; Obdeijn IM; Aksoy Ozcan U; Pediconi F; Pinker K; Preibsch H; Raya Povedano JL; Rossi Saccarelli C; Sacchetto D; Scaperrotta GP; Schlooz M; Szabó BK; Taylor DB; Ulus SÖ; Van Goethem M; Veltman J; Weigel S; Wenkel E; Zuiani C; Sardanelli F
    Eur Radiol; 2024 Jun; 34(6):3970-3980. PubMed ID: 37999727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
    Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
    Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
    van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI.
    Lai HW; Chang YL; Chen ST; Chang YJ; Wu WP; Chen DR; Kuo SJ; Liao CY; Wu HK
    World J Surg Oncol; 2021 Sep; 19(1):263. PubMed ID: 34470633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
    Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
    Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.
    Miceli R; Gao Y; Qian K; Heller SL
    AJR Am J Roentgenol; 2023 Jul; 221(1):34-43. PubMed ID: 36752370
    [No Abstract]   [Full Text] [Related]  

  • 13. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.
    Mori K; Takeda M; Kodama Y; Kiyokawa H; Yasojima H; Mizutani M; Otani Y; Morikawa N; Masuda N; Mano M
    Hum Pathol; 2017 Jun; 64():145-155. PubMed ID: 28434924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
    Hussein H; Chung C; Moshonov H; Miller N; Kulkarni SR; Scaranelo AM
    Acad Radiol; 2015 Dec; 22(12):1483-8. PubMed ID: 26391856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of preoperative breast MRI in ductal carcinoma in situ for prediction of the presence and assessment of the extent of occult invasive component.
    Nori J; Meattini I; Giannotti E; Abdulcadir D; Mariscotti G; Calabrese M; Angelino F; Chiesa F; Saieva C; Vanzi E; Boeri C; Bianchi S; Sanchez L; Orzalesi L; Casella D; Susini T; Livi L
    Breast J; 2014; 20(3):243-8. PubMed ID: 24750509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
    Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ.
    Itakura K; Lessing J; Sakata T; Heinzerling A; Vriens E; Wisner D; Alvarado M; Esserman L; Ewing C; Hylton N; Hwang ES
    Clin Breast Cancer; 2011 Mar; 11(1):33-8. PubMed ID: 21421520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?
    Rizzo V; Cicciarelli F; Galati F; Moffa G; Maroncelli R; Pasculli M; Pediconi F
    Acta Radiol; 2024 Jun; 65(6):565-574. PubMed ID: 38196268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
    Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
    Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.